Cargando…

Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance

Detalles Bibliográficos
Autores principales: Oh, Johnathan, Barve, Minal, Senzer, Neil, Aaron, Phylicia, Manning, Luisa, Wallraven, Gladice, Bognar, Ernest, Stanbery, Laura, Horvath, Staci, Manley, Meghan, Nemunaitis, John, Walter, Adam, Rocconi, Rodney P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752749/
https://www.ncbi.nlm.nih.gov/pubmed/33364285
http://dx.doi.org/10.1016/j.gore.2020.100648
_version_ 1783625933363609600
author Oh, Johnathan
Barve, Minal
Senzer, Neil
Aaron, Phylicia
Manning, Luisa
Wallraven, Gladice
Bognar, Ernest
Stanbery, Laura
Horvath, Staci
Manley, Meghan
Nemunaitis, John
Walter, Adam
Rocconi, Rodney P.
author_facet Oh, Johnathan
Barve, Minal
Senzer, Neil
Aaron, Phylicia
Manning, Luisa
Wallraven, Gladice
Bognar, Ernest
Stanbery, Laura
Horvath, Staci
Manley, Meghan
Nemunaitis, John
Walter, Adam
Rocconi, Rodney P.
author_sort Oh, Johnathan
collection PubMed
description
format Online
Article
Text
id pubmed-7752749
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77527492020-12-23 Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance Oh, Johnathan Barve, Minal Senzer, Neil Aaron, Phylicia Manning, Luisa Wallraven, Gladice Bognar, Ernest Stanbery, Laura Horvath, Staci Manley, Meghan Nemunaitis, John Walter, Adam Rocconi, Rodney P. Gynecol Oncol Rep Correspondence Elsevier 2020-09-17 /pmc/articles/PMC7752749/ /pubmed/33364285 http://dx.doi.org/10.1016/j.gore.2020.100648 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Correspondence
Oh, Johnathan
Barve, Minal
Senzer, Neil
Aaron, Phylicia
Manning, Luisa
Wallraven, Gladice
Bognar, Ernest
Stanbery, Laura
Horvath, Staci
Manley, Meghan
Nemunaitis, John
Walter, Adam
Rocconi, Rodney P.
Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_full Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_fullStr Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_full_unstemmed Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_short Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
title_sort long-term follow-up of phase 2a trial results involving advanced ovarian cancer patients treated with vigil® in frontline maintenance
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752749/
https://www.ncbi.nlm.nih.gov/pubmed/33364285
http://dx.doi.org/10.1016/j.gore.2020.100648
work_keys_str_mv AT ohjohnathan longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT barveminal longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT senzerneil longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT aaronphylicia longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT manningluisa longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT wallravengladice longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT bognarernest longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT stanberylaura longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT horvathstaci longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT manleymeghan longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT nemunaitisjohn longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT walteradam longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance
AT rocconirodneyp longtermfollowupofphase2atrialresultsinvolvingadvancedovariancancerpatientstreatedwithvigilinfrontlinemaintenance